ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional

A Study of Tirzepatide (LY3298176) Compared With Placebo in Adults With Type 1 Diabetes and Obesity or Overweight

ClinicalTrials.gov ID: NCT06914895

Public ClinicalTrials.gov record NCT06914895. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 6, 2026, 8:51 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Evaluating the Efficacy and Safety of Tirzepatide Once Weekly Compared to Placebo in Adult Participants With Type 1 Diabetes and Obesity or Overweight

Study identification

NCT ID
NCT06914895
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Eli Lilly and Company
Industry
Enrollment
905 participants

Conditions and interventions

Interventions

  • Placebo Drug
  • Tirzepatide Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 24, 2025
Primary completion
Oct 31, 2026
Completion
Nov 30, 2026
Last update posted
Feb 16, 2026

2025 – 2026

United States locations

U.S. sites
31
U.S. states
20
U.S. cities
30
Facility City State ZIP Site status
Sansum Diabetes Research Institute Santa Barbara California 93105
Care Access - Santa Clarita Santa Clarita California 91321
University of Colorado Anschutz Medical Campus Aurora Colorado 80045
Atlanta Diabetes Associates Atlanta Georgia 30318
Orita Clinical Research Decatur Georgia 30034
North Georgia Clinical Research Woodstock Georgia 30189
East-West Medical Research Institute Honolulu Hawaii 96814
Rocky Mountain Clinical Research Idaho Falls Idaho 83404
Southern Illinois University School of Medicine Springfield Illinois 62702
Indiana University Health University Hospital Indianapolis Indiana 46202
Iowa Diabetes and Endocrinology Research Center West Des Moines Iowa 50266
Endocrine and Metabolic Consultants Rockville Maryland 20852
HealthPartners Institute dba International Diabetes Center Minneapolis Minnesota 55416
SKY Integrative Medical Center/SKYCRNG Ridgeland Mississippi 39157
Boeson Research MSO Missoula Montana 59804
Palm Research Center Tenaya Las Vegas Nevada 89128
Palm Research Center Sunset Las Vegas Nevada 89148
Albany Medical College, Division of Community Endocrinology Albany New York 12203
Research Foundation of SUNY - University of Buffalo Buffalo New York 14221
NYC Research New York New York 10016
SUNY Upstate Medical University Syracuse New York 13210
Lucas Research, Inc. Morehead City North Carolina 28557
Care Access - Lima Lima Ohio 45805
Alliance for Multispecialty Research, LLC Norman Oklahoma 73069
Suburban Research Associates West Chester Pennsylvania 19380
Texas Diabetes & Endocrinology, P.A. Austin Texas 78731
Velocity Clinical Research, Dallas Dallas Texas 75230
Tekton Research, LLC. McKinney Texas 75069
Medrasa Clinical Research Wylie Texas 75098
Eastside Research Associates Redmond Washington 98052
Rainier Clinical Research Center Renton Washington 98057

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 115 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06914895, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 16, 2026 · Synced May 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06914895 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →